The BTA guidelines on liothyronine state 'T3 does not cross the placenta'. There is some truth in this in that type 3 deiodinase (D3) in placenta converts T3 to T2. However, they fail to point out that D3 also converts T4 to rT3. The transport of T3 and T4 across the placenta is very complex but the evidence is both hormones get from the mother to the foetus. There have been numrous successful pregnancies to mothers on liothyronine with very low fT4. I have sent the following email to the BTA asking for evidence.
Sense About Science - Ask For Evidence
Bijay,
The BTA 'Patient leaflet about the use of liothyronine (T3) in hypothyroidism' btf-thyroid.org/patient-lea... asserts 'L-T3 is not recommended in pregnancy since it does not cross the placenta'.
Please supply evidence that T3 does not cross the placenta and T4 does.
Background:
Many sources claim 'T3 does not cross the placenta' (and implicitly imply T4 does). In each case they cite a previous publication that makes the same assertion but none cite a study that shows T4 crosses the placenta and T3 does not. The 'evidence' seems to consist of 'Chinese wispers'.
Until the introduction of levothyroxine ALL babies were born to mothers on 'combination therapy', usually a combination of T3 and T4 from the mother's thyroid.
I am asking as part of the Ask for Evidence campaign and will share the response I get publicly.
Thank-you for your assistance,
Jim Harwood.